Concepedia

Jen-Pyng Kou

JK

3

Publications

336

Citations

3

H-Index

2009

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

Jen-Pyng Kou is an author at GlaxoSmithKline (United States) specializing in cell signaling, oxidative stress, and drug discovery.

Top concepts

Publications per year

2009–2017

3

Publications

3

Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein–Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery

Thomas G. Davies, William E. Wixted, Joseph E. Coyle et al. · Journal of Medicinal Chemistry · 2016 · 295 citations · Full text

, , +19

The Identification of a Novel Phosphodiesterase 4 Inhibitor, 1-Ethyl-5-{5-[(4-methyl-1-piperazinyl)methyl]-1,3,4-oxadiazol-2-yl}-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (EPPA-1), with Improved Therapeutic Index using Pica Feeding in Rats as a Measure of Emetogenicity

Trong Davis, John J. Peterson, Jen-Pyng Kou et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 21 citations

Characterization of the Potent, Selective Nrf2 Activator, 3-(Pyridin-3-Ylsulfonyl)-5-(Trifluoromethyl)-2H-Chromen-2-One, in Cellular and In Vivo Models of Pulmonary Oxidative Stress

John Yonchuk, Joseph P. Foley, Brian Bolognese et al. · Journal of Pharmacology and Experimental Therapeutics · 2017 · 20 citations · Full text

Rows per page

1–3 of 3